ask="N/A"
ask_size="N/A"
average_daily_volume="43373"
bid="14.50"
bid_size="1000"
book_value="5.49"
change="+0.02"
change_from_200_day_moving_average="-1.04"
change_from_50_day_moving_average="-0.43"
change_from_52_week_high="-5.22"
change_From_52_week_low="2.46"
change_in_percent="+0.13%"
close="15.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.59"
ebitda="-58.21M"
eps_estimate_current_year="-3.87"
eps_estimate_next_quarter="-0.96"
eps_estimate_next_year="-3.58"
ex_dividend_date="N/A"
float_shares="9274000"
high="15.75"
high_52_weeks="20.74"
last_trade_date="3/16/2017"
last_trade_price="15.52"
last_trade_size="1827"
last_trade_time="4:00pm"
low="15.32"
low_52_weeks="13.06"
market_capitalization="339.72M"
moving_average_200_day="16.56"
moving_average_50_day="15.95"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="15.57"
pe_ratio="N/A"
peg_ratio="-0.63"
percent_change_from_200_day_moving_average="-6.29%"
percent_change_from_50_day_moving_average="-2.73%"
percent_change_from_52_week_high="-25.17%"
percent_change_from_52_week_low="+18.84%"
previous_close="15.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.82"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21889000"
short_ratio="19.63"
stock_exchange="NGM"
symbol="BOLD"
volume="59675"
weeks_range_52="13.06 - 20.74"
